Niclosamide treatment of cestodiasis. Clinicial trials in the United States.
D000871:Anthelmintics / Q000627:therapeutic use*; D002590:Cestode Infections / Q000188:drug therapy*; D004169:Diphyllobothriasis / Q000188:drug therapy; D004170:Diphyllobothrium; D005243:Feces; D005500:Follow-Up Studies; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy; D009534:Niclosamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use; D012457:Salicylamides / Q000627:therapeutic use*; D013621:Taenia; D013622:Taeniasis / Q000188:drug therapy; D014481:United States
D000871:Anthelmintics; D012457:Salicylamides; D009534:Niclosamide; D011796:Quinacrine